
Psychedelics Guide › Harm Reduction and Responsible Drug Use
Harm reduction is a public health approach grounded in respect for individuals and their autonomy: anyone who chooses to use a substance has the right to do so with accurate, practical information that allows them to protect their health. It does not seek to encourage drug use or replace the judgment of medical professionals; its goal is to reduce avoidable risks, whether stemming from the substances themselves or from the context in which they are used. In this guide, we bring together Psiconáutica’s articles addressing responsible use through evidence, without providing how-to instructions.
A significant portion of serious incidents is not caused by the substance itself, but by uncertainty surrounding its composition: in an unregulated market, purity is never guaranteed, and adulteration, confusion between similar molecules, and unpredictable dosing account for the vast majority of emergencies. That is why we emphasize findings from forensic laboratories and drug checking services, the critical importance of dosage and route of administration, and combinations that multiply risk. This is educational, general information that does not replace an individualized medical or toxicological evaluation.
If you or someone around you is going through a difficult time with drugs, or at any sign of overdose or emergency, the wisest course of action is to contact emergency services and professional treatment and harm reduction resources immediately. The contents of this website are intended for educational and critical-thinking purposes, designed for adults who wish to make their own informed decisions with more and better information.
Featured Reading
- Harm reduction: between scientific evidence and political rhetoric
- LSD: acute effects, pharmacological profile, and harm reduction
- Ecstasy and health: a rigorous analysis of physical and psychiatric risks
- Ayahuasca: science, tradition, and harm reduction
- Cannabis adulterants: what laboratory tests reveal
- Naloxone and opioid overdoses: clinical evidence and social barriers
What Harm Reduction Is and Why Stigma-Free Information Matters
Harm reduction starts from a simple premise: regardless of drug policy, people use drugs, and providing accurate information reduces preventable risks. These articles explain the approach, its evidence base, and why rigorous information is not the same as encouraging drug use.
- Harm reduction: between scientific evidence and political rhetoric
- Pleasures and risks: a new way to inform about drugs
- Sustainable Hedonism (VII): safer drugs and stigma-free users
Substance Testing, Purity, and Adulteration
Much of the danger in the illicit market comes from not knowing what a substance actually contains. We examine what forensic analyses and drug checking services reveal about adulterants, purity, and hazardous mix-ups such as LSD versus 25I-NBOMe.
- Cannabis adulterants: what laboratory tests reveal
- Cannabis adulterants: what forensic analyses show
- Hashish adulterants: what do laboratories uncover?
- Ecstasy purity and adulteration: historical data from the Spanish market (1985–1995)
- Market volatility: MDMA purity and adulteration in Spain
- The crystal deception: methamphetamine sold as ecstasy in Spain
- Purity and duration: key insights into cocaine
- Cocaine purity and adulteration: the reality of the illicit market
- The truth about rat poison in street drugs: history, science, and myths
- How to tell the difference between LSD and 25I-NBOMe
- Ecstasy cut with heroin: anatomy of a myth
Dosage, Tolerance, and Storage
Dose and route of administration fundamentally alter the risk profile, particularly with edibles. These articles explore dosing, tolerance, and what is known about shelf life and preservation across various substances, always with caution and without user manuals.
- Dosing ingested cannabis
- Edible cannabis: why dosage changes everything
- Tolerance and diminishing effects: pharmacological insights into MDMA
- Shelf life of psychoactive substances: chemical stability and environmental factors
- The truth about preserving amphetamines: myths versus scientific reality
- Storing and preserving cannabis flower
- Wet hashish: how to recover it and when to discard it
Risk Profiles: Stimulants
Cocaine, crack, amphetamines, and MDMA share stimulant pharmacology with distinct cardiovascular and overstimulation risks. Here we separate data from myths regarding their toxicity and both short- and long-term effects.
- Cocaine: pharmacology, risks, and myths of a stimulant
- Crack and freebase cocaine (II): risks and harm reduction
- Amphetamines: history, pharmacology, and risks of a stimulant
- Ecstasy and the brain: between the myth of neurotoxicity and clinical reality
- Ecstasy and health: a rigorous analysis of physical and psychiatric risks
Psychedelics, Visionary Plants, and Novel Substances
From ayahuasca to LSD and synthetic cannabinoids, context (set and setting), potency, and the emergence of novel psychoactive substances shape safety. We review evidence on effects, contraindications, and specific dangers of designer compounds.
- LSD: acute effects, pharmacological profile, and harm reduction
- Ayahuasca: science, tradition, and harm reduction
- Long-term effects of ritual ayahuasca use: scientific evidence and harm reduction
- Synthetic cannabinoids: the shadow of modern recreation
- Synthetic cannabinoids: the Spice phenomenon and its hidden risks
- Synthetic cannabinoids: between legal loopholes and life-threatening danger
- Research Chemicals: Tryptamines and Phenethylamines (I)
Opioids: Overdose Prevention and Dependence Treatment
Opioids account for a large portion of preventable mortality. These articles examine naloxone and overdose reversal, fentanyl potency, and maintenance and assisted therapies (methadone, buprenorphine, naltrexone) from a harm reduction perspective.
- Naloxone and opioid overdoses: clinical evidence and social barriers
- Fentanyl: lethal potency, medical paradox, and harm reduction
- Methadone in opioid addiction treatment: history, efficacy, and harm reduction
- Buprenorphine: history, pharmacology, and role in dependence treatment
- Naltrexone: mechanisms, risks, and clinical realities in dependence treatment
- Heroin-assisted treatment: scientific evidence and harm reduction
- Ibogaine and addiction: the clinical evidence mainstream medicine ignores
- Levo-alpha-acetylmethadol: clinical history of a forgotten opioid
Contexts of Use: Driving, Chemsex, and Nightlife
The same substance carries different risks depending on context. We address cannabis and driving, testing limitations, chemsex beyond sensationalism, and risk comparisons with everyday activities.
- Cannabis and driving: risks, tolerance, and roadside drug testing complexities
- Cannabis, health, and driving: between pain management and roadside checkpoints
- Urine drug screens: scientific realities and misconceptions surrounding cannabis
- Chemsex: between scientific data and media sensationalism
- Chemsex: clinical reality versus media narrative
- Mountaineering risks versus MDMA: a medical-statistical comparison
- Winter sports and MDMA: a rigorous comparison of mortal risks
- Quitting tobacco with cannabis: a critical examination
Debunking Dangerous Urban Legends
Disinformation causes direct harm by feeding panic or encouraging recklessness. We dissect recurring urban legends and hoaxes about drugs to separate myth from actual risk.
- Burundanga: between media myth and toxicological reality
- Sisa or “poor man’s drug”: anatomy of a media panic
- LSD transfer tattoos: anatomy of an urban legend
- Cannabis “spiked” with LSD: anatomy of a hoax
- The urban legend of HIV-infected needles in movie theater seats
- Getting high on batteries: anatomy of an urban legend
More Articles on This Topic
Additional Psiconáutica reading related to harm reduction and drug policy.
- Heroin in the 21st century: between historical stigma and scientific evidence
- Drugs and mental health: between scientific evidence and fear-based myths
- Legal bias in drug research: between fear and science
- The opioid crisis: heroin, morphine, and the pharmaceutical industry
- Consensual forced intoxication: ethics, risks, and dynamics in BDSM
- The shadow of stimulants: methamphetamine and new challenges for Europe
- Coca leaf and ephedra: a European legal paradox
Frequently Asked Questions
What exactly is harm reduction?
Harm reduction is a set of public health strategies aimed at reducing negative consequences associated with drug use without requiring abstinence as a prerequisite. It starts from respect for autonomy and human rights, prioritizing practical, evidence-based measures such as accurate information, drug checking services, and overdose prevention. It neither encourages nor condemns drug use: it recognizes that use exists and works to make it as safe as possible.
How can I tell if a substance is adulterated?
You cannot tell by sight alone: appearance, color, or taste do not reveal actual composition or purity. In Spain and other countries, drug checking services test submitted samples voluntarily and confidentially, reporting any detected adulterants. Home colorimetric reagent test kits provide preliminary clues, but have clear limitations: they cannot distinguish between related analogs or determine purity and dosage, so they should be treated as guidance rather than a guarantee.
Is combining different drugs dangerous?
Mixing substances tends to amplify risks in unpredictable ways. Combining depressants (such as alcohol and opioids) compounds respiratory depression; combining stimulants strains the cardiovascular system; and pairings like alcohol and MDMA increase dehydration while masking physical warning signs. Because interactions depend on individual tolerance, dose, and setting, taking multiple substances requires extreme caution and prior research.
What is naloxone and how does it work?
Naloxone is an opioid antagonist that temporarily reverses an opioid overdose (from heroin, fentanyl, methadone, etc.), restoring normal breathing within minutes. It is administered via nasal spray or injection, and with potent synthetic opioids like fentanyl, multiple doses may be required. It is a life-saving tool, but does not replace medical attention: whenever an overdose is suspected, contacting emergency medical services immediately remains essential.
How long does cannabis remain detectable, and what does that mean for driving?
Detection windows depend on the test type and consumption patterns. In oral fluid, THC is typically detectable for several hours to a few days; in urine, it can remain detectable from several days for occasional users up to several weeks for regular consumers, because THC metabolites accumulate in fatty tissue. A positive test result does not directly indicate acute impairment; nevertheless, driving under the influence of any psychoactive substance significantly increases accident risks, in addition to potential legal penalties.
Does providing information about drugs encourage their use?
Public health evidence shows the exact opposite: withholding information does not stop people from using drugs, but it does leave them far more vulnerable to fatal mistakes. Sharing rigorous facts—covering risks, proper dosing, dangerous combinations, and common myths—enables safer decisions and demonstrably reduces harm. This approach is fully compatible with prevention, giving individuals objective facts to decide freely, including choosing not to use.